DT&CRO CO., Ltd. (KOSDAQ:383930)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,430.00
+230.00 (5.48%)
At close: May 12, 2025, 3:30 PM KST
-45.64%
Market Cap 55.70B
Revenue n/a
Net Income n/a
Shares Out 12.73M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 456,505
Average Volume 849,313
Open 4,200.00
Previous Close 4,200.00
Day's Range 4,180.00 - 4,455.00
52-Week Range 4,100.00 - 10,600.00
Beta 3.96
RSI 36.80
Earnings Date n/a

About DT&CRO CO.

DT&CRO CO., Ltd. operates as a full-service CRO provider in South Korea. It conducts a series of consigned studies ranging from non-clinical GLP toxicity, PK, and efficacy tests required for licensing of pharmaceuticals, chemicals, health functional foods, cosmetics, and medical devices to analysis, bioactivity, clinical trials, and licensing consulting. DT&CRO CO., Ltd. was founded in 2017 and is based in Yongin, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2017
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 383930
Full Company Profile

News

There is no news available yet.